The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine ...
Oct 28, 2020
8
1559
As the COVID-19 pandemic continues with many thousands of new infections reported each day, there is a need for widely applicable surveillance testing to gain a better understanding of infection rates, especially the number ...
Jun 11, 2020
0
295
Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest that tests with the new ...
Jan 3, 2022
0
186
A team of researchers affiliated with several institutions in the U.S. has identified circadian rhythm patterns in human skin based on genetic biomarkers. In their paper published in Proceedings of the National Academy of ...
Two different types of detectable antibody responses in SARS-CoV-2 (COVID-19) tell very different stories and may indicate ways to enhance public health efforts against the disease, according to researchers at The University ...
Aug 14, 2020
0
62
Most people in the United States have some degree of immune protection against COVID-19, either from vaccination, infection, or a combination of the two. But, just how much protection does any individual person have?
Aug 9, 2022
0
46
Two mRNA vaccines against COVID-19 have proven safe and effective in clinical trials, as well as in the millions of people who have been vaccinated so far. But how prior SARS-CoV-2 infection affects vaccine response, and ...
Jun 23, 2021
0
6
A new technology being tested by University of Alberta scientists could revolutionize human papillomavirus (HPV) related cancer diagnostics and cervical cancer screening.
Nov 5, 2018
0
20
As SARS-CoV-2 has the potential to mutate, it is important to check the efficacy of current diagnostic tests, say York University researchers, who found seven out of 27 methods had potential sequence mismatch issues that ...
Jun 10, 2020
0
154
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19.
Dec 10, 2020
0
94
